A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.

نویسندگان

  • Frank Jessen
  • Rebecca E Amariglio
  • Martin van Boxtel
  • Monique Breteler
  • Mathieu Ceccaldi
  • Gaël Chételat
  • Bruno Dubois
  • Carole Dufouil
  • Kathryn A Ellis
  • Wiesje M van der Flier
  • Lidia Glodzik
  • Argonde C van Harten
  • Mony J de Leon
  • Pauline McHugh
  • Michelle M Mielke
  • Jose Luis Molinuevo
  • Lisa Mosconi
  • Ricardo S Osorio
  • Audrey Perrotin
  • Ronald C Petersen
  • Laura A Rabin
  • Lorena Rami
  • Barry Reisberg
  • Dorene M Rentz
  • Perminder S Sachdev
  • Vincent de la Sayette
  • Andrew J Saykin
  • Philip Scheltens
  • Melanie B Shulman
  • Melissa J Slavin
  • Reisa A Sperling
  • Robert Stewart
  • Olga Uspenskaya
  • Bruno Vellas
  • Pieter Jelle Visser
  • Michael Wagner
چکیده

There is increasing evidence that subjective cognitive decline (SCD) in individuals with unimpaired performance on cognitive tests may represent the first symptomatic manifestation of Alzheimer's disease (AD). The research on SCD in early AD, however, is limited by the absence of common standards. The working group of the Subjective Cognitive Decline Initiative (SCD-I) addressed this deficiency by reaching consensus on terminology and on a conceptual framework for research on SCD in AD. In this publication, research criteria for SCD in pre-mild cognitive impairment (MCI) are presented. In addition, a list of core features proposed for reporting in SCD studies is provided, which will enable comparability of research across different settings. Finally, a set of features is presented, which in accordance with current knowledge, increases the likelihood of the presence of preclinical AD in individuals with SCD. This list is referred to as SCD plus.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Subjective Cognitive Decline as a Preclinical Marker for Alzheimer's Disease: The Challenge of Stability Over Time

Subjective Cognitive Decline (SCD) refers to a self-experienced persistent decline in cognitive abilities in comparison with a prior normal status and independent of the objective performance on neuropsychological tests (Jessen et al., 2014). It has been proposed that SCDmight appear at the end of the preclinical phase of Alzheimer’s Disease (AD) even in the absence of significant objective imp...

متن کامل

Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample

INTRODUCTION Subjective cognitive decline (SCD) and biomarker-based "at-risk" concepts such as "preclinical" Alzheimer's disease (AD) have been developed to predict AD dementia before objective cognitive impairment is detectable. We longitudinally evaluated cognitive outcome when using these classifications. METHODS Memory clinic patients (n = 235) were classified as SCD (n = 122): subtle cog...

متن کامل

Reduced Gray Matter Volume in Subjective Cognitive Decline: A Voxel-Based Morphometric Study

Persons with subjective cognitive decline are reported to experience a decline in cognitive capacity without measurable cognitive deficits on objective testing.1 In a meta-analysis, subjective cognitive decline was present in about 17% of healthy elderly.2 The pathophysiological process of Alzheimer’s disease (AD) is thought to begin many years before the diagnosis of AD dementia.3 Subjective c...

متن کامل

Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.

BACKGROUND Subjective cognitive decline (SCD) may result from many conditions, including Alzheimer's disease (AD). OBJECTIVE In this study, we searched for a specific pattern of SCD in asymptomatic individuals at risk for AD. METHODS Cognitively normal older adults (N = 318) reporting SCD and their informants were enrolled in the INSIGHT-PreAD cohort. We examined the relationship between si...

متن کامل

Long-term forgetting in preclinical Alzheimer's disease

Alzheimer’s disease is characterised by progressive pathophysiological changes that correspond roughly to preclinical (ie, cognitively unimpaired), mild cognitive impairment, and dementia stages. Biomarkers continue to be developed, tested, and used to detect and track the pathophysiological manifestations of this disease. Although neuropsychological tests, clinical ratings, and composite cogni...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Alzheimer's & dementia : the journal of the Alzheimer's Association

دوره 10 6  شماره 

صفحات  -

تاریخ انتشار 2014